Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules-Reference-Cited by-同舟云学术

Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules

Published:2020-06-08 Issue:8 Volume:17 Page:2925-2937
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Sabri Akmal¹,Ogilvie Jane²,McKenna John³,Segal Joel⁴,Scurr David¹,Marlow Maria¹^ORCID

Affiliation:

1. School of Pharmacy, University of Nottingham, Nottingham NG72RD, United Kingdom

2. Walgreens Boots Alliance, Thane Road, Nottingham NG90 1BS, United Kingdom

3. Leicester Royal Infirmary University Hospitals Leicester Dermatology Department, Infirmary Square, Leicester LE1 5WW, United Kingdom

4. Department of Mechanical, Materials and Manufacturing Engineering, Faculty of Engineering, University of Nottingham, Nottingham NG8 1BB, United Kingdom

Funder

Engineering and Physical Sciences Research Council

Walgreens Boots Alliance, Inc.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00347

Reference78 articles.

1. Basal cell carcinoma: Epidemiology, clinical and histologic features, and basic science overview

2. Episodic progression and regression of basal cell carcinomas